FRI technology showed substantial and homogeneous vasodilation during phase one research for new PAH medication.
February 2, 2023 1:12 pmPulmonary Hypertension (PH) patients need more treatment options, and it seems the Merck’s MK5475 inhaled drug is quite promising! FLUIDDA’s FRI technology showed substantial and homogeneous vasodilation throughout the lung... View Article